Edition:
United Kingdom

People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

128.81USD
7:25pm BST
Change (% chg)

$-2.46 (-1.87%)
Prev Close
$131.27
Open
$131.07
Day's High
$131.22
Day's Low
$127.33
Volume
1,622,335
Avg. Vol
2,079,242
52-wk High
$148.97
52-wk Low
$122.00

Duato, Joaquin 

Mr. Joaquin Boix Duato is the Vice Chairman - Executive Committee of the Company. Mr. Duato joined the Company in 1989 with Janssen-Farmaceutica S.A. (Spain) and in 1997 became Managing Director of Janssen-Cilag S.p.A. (Italy). In 2000, he led Ortho Biotech Europe before relocating to the United States in 2002 to serve as Vice President, and, in 2005, President of Ortho Biotech Inc. In 2008, he was named Company Group Chairman, Ortho-Clinical Diagnostics, and in 2009, Company Group Chairman, Pharmaceuticals, where he oversaw pharmaceutical product launches and the major therapeutic franchises in Canada, the United States and Latin America. In 2011, he was named Worldwide Chairman, Pharmaceuticals, responsible for the global commercial businesses of the Janssen Pharmaceutical Companies, including functional support for the research & development organizations. In April 2016, Mr. Duato became a member of the Executive Committee and was named Executive Vice President, Worldwide Chairman, Pharmaceuticals.

Basic Compensation

Total Annual Compensation, USD 2,944,130
Restricted Stock Award, USD 4,275,950
Long-Term Incentive Plans, USD --
All Other, USD 2,063,880
Fiscal Year Total, USD 9,283,960

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 50,000 3,193,720.00
Name Fiscal Year Total

Alex Gorsky

20,097,600

Paulus Stoffels

10,591,800

Joaquin Duato

9,283,960

Joseph Wolk

2,708,190

Peter Fasolo

3,621,280

Michael Ullmann

5,336,150
As Of  31 Dec 2018